Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Other financing activities (2018 - 2024)

Historic Other financing activities for Catheter Precision (VTAK) over the last 4 years, with Q2 2024 value amounting to $309000.0.

  • Catheter Precision's Other financing activities changed N/A to $309000.0 in Q2 2024 from the same period last year, while for Jun 2024 it was $768000.0, marking a year-over-year increase of 4436.09%. This contributed to the annual value of $640000.0 for FY2023, which is N/A changed from last year.
  • According to the latest figures from Q2 2024, Catheter Precision's Other financing activities is $309000.0.
  • In the past 5 years, Catheter Precision's Other financing activities ranged from a high of $872000.0 in Q3 2022 and a low of -$1.5 million during Q1 2022
  • Moreover, its 3-year median value for Other financing activities was $181000.0 (2023), whereas its average is -$31285.7.
  • Within the past 5 years, the most significant YoY rise in Catheter Precision's Other financing activities was 11191.57% (2023), while the steepest drop was 12075.69% (2023).
  • Over the past 3 years, Catheter Precision's Other financing activities (Quarter) stood at $872000.0 in 2022, then decreased by 26.61% to $640000.0 in 2023, then plummeted by 51.72% to $309000.0 in 2024.
  • Its last three reported values are $309000.0 in Q2 2024, $640000.0 for Q4 2023, and -$181000.0 during Q3 2023.